LOS ANGELES & SINGAPORE, June 8
(BUSINESS WIRE) --
MedTech Innovator, the
world’s largest accelerator of medical technology companies announced today
that 24 medtech companies will participate in the fourth annual Asia Pacific
Accelerator program.
MedTech Innovator Asia Pacific offers best-in-class
startups opportunities to work with investors, business leaders and allied
service professionals in the medtech industry to help drive commercialization
of life-changing technologies throughout the region. The 2023 cohort companies
will also compete for up to US$ 300,000 in cash prizes and awards.
“As the world’s largest accelerator of medtech
companies, MedTech Innovator established the Asia Pacific Program in 2019
because of the incredible innovation in the region. We look forward to working
with our partners to support this year’s cohort of companies and to help them
advance their technologies,” said Paul Grand, CEO of MedTech Innovator.
Over 400 companies applied for the Asia Pacific
program this year, and after a rigorous selection process, 60 companies were
invited to pitch, 24 of which were named to the 2023 cohort. In early December,
four startups from the 2023 Asia Pacific cohort will advance to compete in the
Grand Finals to be held at APACMed’s Medtech Forum 2023 in Singapore.
Attended by health care industry leaders, health care providers, and investors
from across the region, the MedTech Forum will also showcase solutions from all
24 Accelerator cohort companies. The winning company, which will be determined
by audience vote, stands to win a non-dilutive cash prize and the title of the
2023 MedTech Innovator Asia Pacific Winner.
For the first time, MedTech Innovator Asia
Pacific’s 2023 cohort will include four shortlisted companies that are part of
the inaugural Olympus Asia Pacific Innovation Program (OAIP). This program
focuses on minimally invasive care and new ways to detect, monitor, and treat
conditions and diseases. The winning innovator will receive grant funding of
US$ 75,000 as well as an exclusive mentorship program with key thought leaders
from within Olympus.
The 24 companies selected to the 2023 MedTech
Innovator Asia Pacific Accelerator are:
- Accuster
Technologies (India)
- Astron Medtech (US)
- Biotome (Australia)
- Flexperc Medical
(US)
- Gbrain (South
Korea)
- GenLight Medical (China)
- Healium Medical (Israel)
- Jdot
(Changzhou) Medical Technology (China)
- Kinexcs (Singapore)
- Lifespans (Hong
Kong, China)
- Medipixel (South
Korea)
- MedySapiens (South
Korea)
- Module Innovations (India)
- Neurowyzr (Singapore)
- NICE Surgical Solutions (Singapore)
- Ossfila Technology (Hong
Kong, China)
- PrimaNova Technologies (Hong
Kong, China)
- Thrixen (Singapore)
- Vivo Surgical (Singapore)
- Weinnovate Biosolutions (India)
The companies shortlisted for the OAIP are:
- BioCliq (India)
- NDR Medical (Singapore)
- Sonire Therapeutics (Japan)
- Vesica
Corporation (US)
MedTech Innovator’s 2023 Asia Pacific program
sponsors include Johnson & Johnson, Olympus, Teleflex, Siemens
Healthineers, B Braun Medical, Cambridge Consultants, JABIL Healthcare and
Enterprise Singapore. The MedTech Innovator Asia Pacific Program is held in
partnership with APACMed.
About MedTech Innovator
Based in Los Angeles, MedTech Innovator is the
world’s largest accelerator of medical technology companies and the premier
nonprofit startup accelerator in the medical technology industry. Its mission
is to improve the lives of patients by accelerating the growth of companies
that are transforming the healthcare system. Since 2013, MedTech Innovator has
reviewed more than 9,000 startups and graduated 509 companies that have gone on
to raise more than $6.8 billion in follow-on funding.
MedTech Innovator works closely with stakeholders
across the industry to promote the growth of early and mid-stage startups. In
collaboration with 35 corporate partners, as well as a broader network of more
than 1,000 industry executives including investors, business development
representatives, and other stakeholders, MedTech Innovator provides startups
with individualized mentorship and feedback, funding opportunities, and continual
engagement with peers and advisors.
For more information about MedTech Innovator, visit
the website, and follow them
on LinkedIn and Twitter. Follow MedTech
Innovator Asia Pacific on LinkedIn.
About Asia Pacific Medical Technology
Association (APACMed)
Founded in 2014 and headquartered in Singapore,
APACMed represents manufacturers and suppliers of medical equipment, devices
and in vitro diagnostics, industry associations and other key stakeholders
associated with the medical technology industry in Asia Pacific.
Providing a unified voice for the medical devices
and in-vitro diagnostics industry in Asia Pacific, APACMed works proactively
with bilateral, regional and local government bodies to shape policies,
demonstrate the value of medical technology and promote regulatory harmonization.
We strive to promote digital health innovation and impact policy that advances
healthcare access for patients by engaging with medical device associations and
companies in Asia Pacific.
APACMed is also host to the annual Asia Pacific
MedTech Forum. www.apacmed.org
Contact
Joe Duraes
Pazanga Health Communications
jduraes@pazangahealth.com
(917) 687-6419
Source : MedTech Innovator
No comments:
Post a Comment